Tiansheng Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 406.39 million compared to CNY 404.75 million a year ago. Revenue was CNY 406.39 million compared to CNY 404.75 million a year ago.

Net loss was CNY 81.83 million compared to CNY 62.58 million a year ago. Basic loss per share from continuing operations was CNY 0.2573 compared to CNY 0.1968 a year ago. Diluted loss per share from continuing operations was CNY 0.2573 compared to CNY 0.1968 a year ago.